{"id":"https://openalex.org/W1604693296","doi":null,"title":"Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.","display_name":"Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.","publication_year":1987,"publication_date":"1987-06-15","ids":{"openalex":"https://openalex.org/W1604693296","mag":"1604693296","pmid":"https://pubmed.ncbi.nlm.nih.gov/2953413"},"language":"en","primary_location":{"id":"pmid:2953413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2953413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045802455","display_name":"David Berd","orcid":"https://orcid.org/0000-0003-2974-9085","observed_orcids":["https://orcid.org/0000-0003-2974-9085"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Berd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110153353","display_name":"Michael J. Mastrangelo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Mastrangelo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2272,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.78995911,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"47","issue":"12","first_page":"3317","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.5288000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.5288000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.22269999980926514,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.15559999644756317,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-dose-cyclophosphamide","display_name":"low-dose cyclophosphamide","score":0.9049999713897705},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7289999723434448},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8090000152587891},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9259999990463257},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.8870000243186951},{"id":"https://openalex.org/keywords/immunopotentiation","display_name":"immunopotentiation","score":0.746999979019165},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.8289999961853027},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.7300000190734863},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.5339999794960022},{"id":"https://openalex.org/keywords/immune-regulation","display_name":"immune regulation","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C19869320","wikidata":"https://www.wikidata.org/wiki/Q419277","display_name":"Concanavalin A","level":3,"score":0.7602629065513611},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.7081946134567261},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.637276828289032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5488461256027222},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48849308490753174},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4677189886569977},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.42986616492271423},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4277162551879883},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4175950288772583},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.410499632358551},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39535507559776306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39140868186950684},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3104665279388428},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3012867569923401},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.24985384941101074},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09763383865356445},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003208","descriptor_name":"Concanavalin A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007107","descriptor_name":"Immune System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010835","descriptor_name":"Phytohemagglutinins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2953413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2953413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1604693296","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2953413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1921725162","https://openalex.org/W2002737769","https://openalex.org/W2521392361","https://openalex.org/W1620275705","https://openalex.org/W1528292250","https://openalex.org/W2059698642","https://openalex.org/W2064200122","https://openalex.org/W2094386328","https://openalex.org/W1999589493","https://openalex.org/W2052194397"],"abstract_inverted_index":{"Low":[0],"dose":[1,201,235],"cyclophosphamide":[2],"(CY)":[3],"can":[4],"augment":[5],"the":[6,25,28,170,212,222,250],"development":[7],"of":[8,34,60,73,181,193,214,233,242,249],"delayed-type":[9],"hypersensitivity":[10],"to":[11,32,80,87,237],"primary":[12],"antigens":[13],"in":[14,110,147,172,185,211,221],"patients":[15,46,239],"with":[16,47,257,266],"advanced":[17],"cancer.":[18],"In":[19,140],"this":[20],"paper,":[21],"we":[22],"have":[23],"considered":[24],"hypothesis":[26],"that":[27,169,253,258,263],"immunopotentiation":[29],"is":[30,254],"related":[31],"reduction":[33,171,184],"T-suppressor":[35,244],"activity.":[36],"Peripheral":[37],"blood":[38,67,187],"lymphocytes":[39,68,195],"were":[40,69],"collected":[41],"and":[42,51,55,82,89,100],"cryopreserved":[43],"from":[44],"45":[45],"metastatic":[48],"malignancy":[49],"before":[50],"then":[52],"3,":[53,114,154],"7,":[54,124,159],"19":[56],"days":[57],"after":[58,229],"administration":[59,232],"CY,":[61],"300":[62],"mg/m2":[63],"i.v.":[64],"The":[65,106,190],"peripheral":[66,186],"tested":[70],"for":[71],"generation":[72],"concanavalin":[74,173],"A-inducible":[75,92,174],"suppressor":[76],"activity,":[77],"proliferative":[78],"response":[79],"phytohemagglutinin,":[81],"phenotype":[83],"using":[84],"monoclonal":[85],"antibodies":[86],"CD4":[88],"CD8.":[90],"Concanavalin":[91],"suppression":[93,111,175],"was":[94,176,196],"significantly":[95],"reduced":[96],"by":[97,199],"day":[98,104,113,123,131,153,158,163],"3":[99],"declined":[101],"progressively":[102],"through":[103],"19.":[105],"mean":[107],"percentage":[108,151,213],"changes":[109,146,210],"were:":[112],"-23.4":[115],"+/-":[116,126,134,156,161,166],"6.8":[117],"(SE)":[118],"(P":[119,128,136],"less":[120,137],"than":[121,138],"0.01);":[122],"-33.1":[125],"14.3":[127],"=":[129],"0.052);":[130],"19,":[132,164],"-43.1":[133],"10.7":[135],"0.01).":[139],"contrast,":[141],"CY":[142,236],"caused":[143,240],"no":[144,208],"significant":[145,209],"phytohemagglutinin":[148],"proliferation":[149],"(mean":[150],"changes:":[152],"-4.7":[155],"6.1;":[157],"-15.6":[160],"7.5;":[162],"-5.5":[165],"8.1),":[167],"indicating":[168],"not":[177,197],"merely":[178],"a":[179,182],"reflection":[180],"general":[183],"lymphocyte":[188],"function.":[189,259],"total":[191],"number":[192],"circulating":[194,215],"affected":[198],"low":[200,234],"CY.":[202,230],"Moreover,":[203],"flow":[204],"cytometric":[205],"analysis":[206],"showed":[207],"CD8+":[216,251],"or":[217,220],"CD4+":[218],"T-cells":[219],"CD4/CD8":[223],"ratio":[224],"at":[225],"any":[226],"time":[227],"point":[228],"Thus,":[231],"these":[238,267],"impairment":[241],"nonspecific":[243],"function":[245],"without":[246],"selective":[247],"depletion":[248],"subset":[252],"generally":[255],"associated":[256],"Several":[260],"immunoregulatory":[261],"models":[262],"are":[264,269],"consistent":[265],"observations":[268],"discussed.":[270]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}